These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21086689)

  • 1. [Finnish disease heritage].
    Kestilä M; Ikonen E; Lehesjoki AE
    Duodecim; 2010; 126(19):2311-20. PubMed ID: 21086689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Database for the mutations of the Finnish disease heritage.
    Sipilä K; Aula P
    Hum Mutat; 2002 Jan; 19(1):16-22. PubMed ID: 11754099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Linkage and linkage disequilibrium in the Finnish disease heritage].
    de la Chapelle A; Hästbacka J; Lehesjoki AE; Sulisalo T; Kere J; Tahvanainen E; Sistonen P
    Duodecim; 1994; 110(7):654-64. PubMed ID: 8542820
    [No Abstract]   [Full Text] [Related]  

  • 4. High frequencies of human genetic diseases: founder effect with genetic drift or selection?
    Zlotogora J
    Am J Med Genet; 1994 Jan; 49(1):10-3. PubMed ID: 8172234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for haplotype evolution in a nonstationary population.
    Fan R; Lange K
    Theor Popul Biol; 1998 Jun; 53(3):184-98. PubMed ID: 9679319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finnish Disease Heritage I: characteristics, causes, background.
    Norio R
    Hum Genet; 2003 May; 112(5-6):441-56. PubMed ID: 12627295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Finnish hereditary amyloidosis: a mutation in the gelsolin gene].
    Maury P
    Duodecim; 1994; 110(7):675-80. PubMed ID: 8542822
    [No Abstract]   [Full Text] [Related]  

  • 8. The Finnish Disease Heritage III: the individual diseases.
    Norio R
    Hum Genet; 2003 May; 112(5-6):470-526. PubMed ID: 12627297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
    Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
    Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Anders Annual Prize for young researchers 1992. Identification of genes in human diseases].
    Palotie LP
    Nord Med; 1993; 108(2):40-1. PubMed ID: 8433944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular background of the Finnish disease heritage.
    Peltonen L
    Ann Med; 1997 Dec; 29(6):553-6. PubMed ID: 9562523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA2 mutations in 154 finnish male breast cancer patients.
    Syrjäkoski K; Kuukasjärvi T; Waltering K; Haraldsson K; Auvinen A; Borg A; Kainu T; Kallioniemi OP; Koivisto PA
    Neoplasia; 2004; 6(5):541-5. PubMed ID: 15548363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on Finnish genes].
    Kääriäinen H; Palotie L; Kontula K
    Duodecim; 1994; 110(7):639-40. PubMed ID: 8542816
    [No Abstract]   [Full Text] [Related]  

  • 14. Finnish Disease Heritage II: population prehistory and genetic roots of Finns.
    Norio R
    Hum Genet; 2003 May; 112(5-6):457-69. PubMed ID: 12627296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single founder mutation (W380G) in type II protein C deficiency in Finland.
    Levo A; Kuismanen K; Holopainen P; Vahtera E; Rasi V; Holopainen P; Rasi V; Krusius T; Partanen J
    Thromb Haemost; 2000 Sep; 84(3):424-8. PubMed ID: 11019966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of autosomal recessive diseases among the Palestinian Arabs.
    Zlotogora J
    Am J Med Genet; 2002 May; 109(3):176-82. PubMed ID: 11977175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations.
    Kinnunen S; Bonache S; Casals T; Monto S; Savilahti E; Kere J; Järvelä I
    J Cyst Fibros; 2005 Dec; 4(4):233-7. PubMed ID: 16051530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).
    Hästbacka J; Kerrebrock A; Mokkala K; Clines G; Lovett M; Kaitila I; de la Chapelle A; Lander ES
    Eur J Hum Genet; 1999 Sep; 7(6):664-70. PubMed ID: 10482955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Finnish population structure and hereditary diseases].
    Nevanlinna HR
    Duodecim; 1972; 88(1):4-14. PubMed ID: 5013577
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genetic counseling in hereditary diseases in Finland].
    Lönnberg M
    Lakartidningen; 1999 Jan; 96(4):304. PubMed ID: 10024815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.